BACKGROUND/OBJECTIVES: A low folate or low thiamine status may be associated with the risk of preterm delivery, small for gestational age (SGA) offspring and adverse pregnancy outcomes. SUBJECTS/METHODS: 5-Methyltetrahydrofolate (5MTHF) and thiamine diphosphate (TDP) were measured directly in cord-blood erythrocytes (CBEs) of early preterm (n ¼ 26; o32 weeks gestational age; including 50% multiple births), late preterm (n ¼ 38; 32 to o37 weeks; including 24% multiple births) and term newborns (n ¼ 60, 37-42 weeks) via high-performance liquid chromatography and fluorescence detection. Associations between 5MTHF and TDP with gestational age, newborn anthropometrics (birth weight, newborn's length and head circumference) and risk of being SGA were explored. RESULTS: Group comparison as well as multivariate linear regression analysis of cord-blood vitamins revealed that 5MTHF was significantly lower in late preterms compared with terms but did not differ between singletons and multiples. TDP tended to be higher in preterms than in terms and lower in multiples than in singletons in both early and late preterms. Multivariate analysis on birth outcomes showed that 5MTHF was significantly positively associated with gestational age, birth weight and newborn's length. 5MTHF, increasing gestational age and parity were associated with a significantly reduced risk for being SGA, while TDP, multiple births and gender were not associated with the risk for being SGA. CONCLUSIONS: Higher CBE concentrations of 5MTHF were associated with improved birth outcomes. Lower TDP concentrations were observed in multiple births. Future studies evaluating cord-blood vitamin concentrations and their associations with birth outcomes should additionally include dietary intakes and maternal blood concentrations at different stages of pregnancy.
INTRODUCTION
Low birth weight (LBW) and preterm delivery represent risk factors for various acute and chronic health conditions throughout life not only in the developing countries but also in the Western world. [1] [2] [3] [4] In 2010, 8.6% of total births in the developed countries were preterm births. 5 During the past 20 years, the incidences rose continuously, particularly that of very LBW infants (o1500 g) from 0.7% to 1.3% of all pregnancies in all the European countries except Sweden. 5 The contribution of micronutrients to adverse pregnancy outcomes, spontaneous abortion, LBW and preterm delivery are still not fully understood. Folate has been studied widely in relation to birth outcomes, due to its importance in the prevention of neural tube defects. 6, 7 The impact of flour fortified with folic acid on the reduction of neural tube defects has been huge, as recently published in a systematic review. 8, 9 Besides the reduction of neural tube defects, folate has been linked to prematurity, LBW and small for gestational age (SGA). [10] [11] [12] [13] [14] [15] [16] [17] Pregnancy is associated with increased rates of cellular proliferation and enhanced one-carbon metabolism. Due to its involvement as a coenzyme in these one-carbon (methyl-, methylene-) transfer reactions, folate requirements increase during periods of rapid tissue growth, as in pregnancy, due to growing placental, fetal and maternal tissues. [18] [19] [20] 5-Methyltetrahydrofolate (5MTHF), together with vitamin B 12 (in methionine synthase) donates its methyl group to homocysteine, which thereby reacts to methionine, the proteinogenic and starter amino acid of all protein synthesis. The activated form of methionine, S-adenosylmethionine, is essential for the methylation of DNA, RNA and proteins, the hepatic synthesis of creatine and the formation of polyunsaturated phosphatidylcholine. 21 Betaine, vitamins B 6 and B 2 and zinc also have important roles in the above mentioned methyl group transfer reactions. 22 In general, folate is essential for the upkeep, repair and synthesis of DNA, purine and neurotransmitter synthesis, amino-acid metabolism and regulation of gene expression. 23 Another pivotal role in the biosynthesis of deoxyribose and ribose, components of the backbone of DNA, is played by transketolase. Thiamine diphosphate (TDP) serves as a coenzyme in carbohydrate metabolism, especially in pyruvate dehydrogenase, a-ketoglutarate dehydrogenase and transketolase. Requirement of this vitamin may also be elevated in pregnancy, because low thiamine concentrations in women with treated gestational diabetes were related to LBW. 24 Maternal concentrations of thiamine decrease during the course of pregnancy, and at birth, they are lower than cord-blood concentrations. 25, 26 The existence of a specific transporter for the placental transfer to the fetus implies the importance of an optimal thiamine status for the newborn. 27 Furthermore, thiamine intake during pregnancy has been thought to contribute to neuromotor maturity of the newborn. 28 Previous studies have demonstrated an association between maternal folate levels or folate intake during different stages of pregnancy with birth outcomes, indicating the importance of an optimal status as early as in the periconceptional period. [10] [11] [12] [13] [14] However, data on the relation of cord-blood folates to birth outcome are scarce. Even though cord blood seems an easily obtainable material to study vitamins in newborns, there are only few recent studies, to our knowledge, on erythrocyte folate levels from cord blood and their relation to birth outcomes. Generally, erythrocyte folate is a more reliable marker than serum folate, because it represents the long-term intake of folate and is not affected by daily fluctuations. 29 Using the remaining anticoagulated cord-blood samples taken for routine plasma analysis enables the measurement of 5MTHF and TDP directly in blood cells, of which 99% are erythrocytes, without further blood drawing or calculations involving hematocrit.
To our knowledge, few studies have addressed the issue of folate and thiamine status in cord blood of newborns. Thus, we measured 5MTHF and TDP, the biologically active forms of these vitamins directly in cord-blood erythrocytes (CBEs) of preterm and term newborns by high-performance liquid chromatography (HPLC). The analyzed concentrations of these cord-blood vitamins were evaluated with regard to maternal characteristics, gestational age at delivery (GA) and newborn anthropometry (birth weight, newborn's length and head circumference).
MATERIALS AND METHODS
The present study was part of a larger study aimed to evaluate the supply of term and preterm newborns with choline and methyl group donors using umbilical cord plasma and maternal serum. 30 The study was approved by the institutional review board (291/2008BO1), written consent obtained and subjects' data and samples collected in pseudonymized form.
Subjects/population
Pregnant women giving birth at the University Women's Hospital of the University of Tuebingen, Germany were asked for consent to participate in this study at admittance to the delivery unit. The study population consisted of convenience samples of unselected consecutively admitted healthy mothers and their term and preterm newborns. Singleton and multiple births were included. Inclusion criteria were written parental informed consent and the availability of umbilical cord blood and maternal routine data. There were no exclusion criteria.
Data and blood collection
The study group consisted of 124 newborns. Umbilical cord blood was collected into a tube containing EDTA, placed at 4 1C as soon as possible, centrifuged at 1000 g for 10 min at 4 1C. CBE pellets were then harvested o24 h after sampling, temporarily frozen at À 20 1C and later stored at À 80 1C until shipment (on dry ice) and measurement at the FriedrichSchiller-University of Jena, Jena, Germany. Maternal weight and height were measured at entry into the delivery unit by trained personnel, mostly midwives, and recorded in the mother's chart, from where this information was retrieved by the study personnel. Further maternal routine data (age, parity, smoking status) were obtained in a pseudonymized form from the patient files. Data on smoking habits were available for 63% of mothers. Multiple births were analyzed as a separate subgroup. Data of mothers with parity X2 were grouped together because of the small numbers of parity 5 (n ¼ 1, 0.8%), parity 4 (n ¼ 3, 2.5%) and parity 3 (n ¼ 9, 7.4%).
Birth outcomes
GA, birth weight, newborn's length and head circumference were obtained from the patient files. GA was determined by best obstetric estimate based on the first day of the last menstrual period and first trimester ultrasound or assisted conception date.
Preterm birth was defined as newborns born alive before 37 weeks of pregnancy were completed; early preterm and late preterm birth were defined as GAo32 weeks and between 32 and 37 weeks (X 32 and o37 weeks), respectively, according to Blencowe et al. 5 and Engle et al. 31 Data of newborns were categorized into groups according to their GA (early preterm, late preterm and term birth) and separate subgroups for singleton and multiple births in order to assess birth outcomes (see Table 1 ). Accordingly, the five groups were early preterm singleton (n ¼ 13), early preterm multiple (n ¼ 13), late preterm singleton (n ¼ 29), late preterm multiple (n ¼ 9) and term (n ¼ 60). In the early preterm group, there were eight twins and five triplets (one triplet missing); in the late preterm group there were nine twins (one missing) and no triplets.
Birth weight was taken immediately after delivery and determined to the nearest 5 g. Newborns were classified as SGA if their birth weight was below the 10th percentile of birth weight for GA by gender according to the United States national reference table for fetal growth.
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5MTHF and TDP in cord-blood erythrocytes 5MTHF and TDP in CBEs were measured with reversed-phase HPLC and fluorescence detection. 5MTFH was determined according to a method described for whole blood by Leeming et al. 33 with modifications. Briefly, 100 ml of erythrocyte pellets were incubated with 500 ml freshly prepared ascorbic acid solution (20 g/l) for 2 h at 37 1C. Samples were deproteinized by adding 50 ml of cold 11 M perchloric acid and mixed well for 30 s, followed by centrifugation (13 000 r.p.m., 5 min at room temperature); 200 ml of supernatant were neutralized with 30 ml of sodium hydroxide (7 M) and 20 ml were analyzed on a Shimadzu Prominence HPLC (LC-20A) equipped with fluorescence detector (RF 10A XL), both from Shimadzu USA Manufacturing Inc. (Canby, OR, USA). The separation of 5MTHF was achieved using a 7-mm analytical column (Phenyl C18-, 250 Â 4.6 mm 2 ; Trentec, Gerlingen, Germany; set at 40 1C), the mobile phase consisting of 8% methanol (v/v) and formic acid buffer (0.07 M, pH 3.75) at a flow rate of 1 ml/min. 5MTHF in CBEs was detected with excitation/emission set at 295/365 nm and quantified against an external standard (5-methyl-5,6,7,8-tetrahydrofolic acid (calcium salt), Schircks Laboratories, Jona, Switzerland), which was dissolved in 0.01 M soduim hydroxide and further diluted in phosphate buffer (0.01 M, pH 7) for spectrophotometric measurement (290 nm; e ¼ 31 700 l/mol Â cm at pH 7) and finally diluted to physiological concentrations (100-2 000 nmol/l) with freshly prepared ascorbic acid solution (20 g/l). TDP in CBEs was measured by HPLC with fluorescence detection as previously described for the whole-blood samples. 34 In brief, 100 ml of erythrocyte pellets were derivatized with hexacyanoferrat (III) to form fluorescent thiochrome, which was measured with excitation/emission set at 367/435 nm. In contrast to the method of Leeming et al., 33 which uses whole blood, we employed blood cell pellets as a proxy for erythrocytes for the direct measurement of 5MTHF and TDP.
Statistics
Normally distributed continuous variables (maternal characteristics and birth weight) were described using means (s.d.). Skewed data were cubed power-transformed (GA, head circumference, newborn's length) or square root-transformed (5MTHF and TDP) to achieve normal distribution for further analyses and are expressed as geometric mean (95% confidence interval, Cl). For categorical variables (parity, smoking status, early/late preterm birth, singleton/multiple birth, SGA and newborn's gender), frequencies were reported.
Differences in maternal characteristics, birth outcomes and cord-blood vitamins between the five groups were compared using one-way analysis of variance (ANOVA) and Tukey's post-hoc test for continuous variables and chi-square test for categorical variables, respectively. To exclude possible confounding by multiples, group comparisons using one-way ANOVA and Tukey's post-hoc test were repeated with singletons only. Independent sample t-test was applied to compare means of 5MTHF and TDP between twins and triplets. To assess individual differences within pairs of twins, paired t-test was applied.
Simultaneous multivariate linear regression was applied to evaluate both cord-blood vitamins and birth outcome variables. Multivariate logistic regression analysis with a forward approach was used to identify independent predictors for SGA offspring.
Following covariates were included for both linear and logistic regression models: GA, newborn's gender, parity (0, 1, X2), singleton versus multiple births, early preterm birth, late preterm birth, 5MTHF and TDP.
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All tests were two-sided, and P-value o0.05 was considered statistically significant. All statistical analyses were carried out using the Statistical Package of Social Sciences software (SPSS Inc., Chicago, IL, USA; Version 19.0). Table 1 shows maternal characteristics, birth outcomes, 5MTHF and TDP concentrations in cord blood according to the five groups (early preterm singleton, early preterm multiple, late preterm singleton, late preterm multiple and singleton term). Fiftytwo percent of newborns were preterm. Multiple newborns accounted for 18% (n ¼ 22/124) and were all premature. Twentyfour percent of newborns were SGA (n ¼ 30/124), with a significant higher prevalence in each subgroup of the preterms versus the term newborn group.
RESULTS
Maternal characteristics between the different newborn groups only differed in maternal height (ANOVA), but comparison between individual subgroups did not show significant differences in maternal height.
Birth outcomes (GA, birth weight, newborn's length and head circumference) between the five groups differed significantly (Po0.001), given that they were classified by GA. There were no differences in maternal characteristics or birth outcomes between singletons and multiples of the same subgroup.
5MTHF in CBEs was significantly lower in late preterms both in singletons and multiples, compared with terms (see Figure 1a ). There were no differences in 5MTHF between singletons and multiples (P ¼ 0.879 for early preterms and P ¼ 0.521 for late preterms). However, late preterm multiples had lower TDP concentration than late preterm singletons (P ¼ 0.075, Figure 1b) .
When multiple births were excluded, 5MTHF was still significantly lower in preterms (P ¼ 0.008). After excluding multiple births, there was no difference between the groups of singletons concerning TDP (P ¼ 0.199).
There were no significant differences between twins and triplets for 5MTHF (P ¼ 0.113) but for TDP (P ¼ 0.060) with lower concentrations in triplets. There were neither significant differences in either 5MTHF or TDP concentrations (P ¼ 0.853 and P ¼ 0.683, respectively) nor in the characteristics (birth weight, head circumference and newborn's length) within pairs of twins.
Prematurity was a significant determinant for 5MTHF and TDP concentrations in CBEs (Table 2 ). Early and late preterm deliveries were both significant factors for lower 5MTHF, whereas only early preterm delivery was associated with higher TDP concentrations. Parity and multiple births were not associated with 5MTHF but were associated with CBE concentrations of TDP; parity was positively associated with TDP and multiple births had significantly lower TDP than singletons.
Linear regression analysis on birth outcomes adjusted for covariates known to affect outcomes (GA, parity and newborn's gender) revealed that 5MTHF was significantly positively associated with GA, birth weight and the newborn's length (Table 3) . Maternal smoking status and height were not included as covariates because of incomplete data sets (63% for smoking status and 90% for height). However, neither smoking status nor 
Late preterms (X32 and o37 weeks) Terms (X37 weeks) P-value Folate and thiamine status in preterms and terms D Weber et al maternal height were significantly associated with any of the birth outcomes in univariate analyses.
Multiple births and TDP were risk factors for earlier (low) GA, birth weight and newborn's length, being highly significant for GA. Head circumference was not associated with 5MTHF or TDP in CBEs, multiple births or any other covariate.
Logistic regression analysis revealed GA, parity and 5MTHF as independent risk factors for SGA; increasing GA at delivery, parity (0, 1, X2) and 5MTHF in cord blood were significantly associated with a reduced risk for SGA, whereas multiple births, gender and TDP concentrations were not associated with SGA (Table 4) .
DISCUSSION
Previous work has demonstrated the importance of folate requirement due to rapid tissue growth during pregnancy. [18] [19] [20] Undoubtedly, maternal intake of folate and thiamine influences the levels of these vitamins in the fetus, or in other words, deficiency of the mother will evidently result in a deficiency in the fetus that may lead to adverse pregnancy outcomes.
During the last weeks of gestation, there is an increased transport of folate to and an accumulation of folate in the fetus, resulting in higher blood folate concentrations in term and even in preterm newborns in comparison to their mothers and to adults in general. 35, 36 Maternal serum folate was shown to decline significantly during the course of pregnancy especially during multiple pregnancy; when corrected for plasma volume expansion, however, the significance disappeared. 37 Further, multiparity has been shown to significantly reduce maternal folate concentrations. 11, 13 These facts may indicate higher folate requirements in the course of gestation and in multiparity to meet the needs of the fetus.
In the present study, 5MTHF in CBEs was significantly positively associated with GA at delivery and with the newborn's weight and length; 5MTHF was significantly lower in the group of late preterms compared with terms. In accordance to our findings are studies showing a positive correlation between blood folate and GA and significantly lower whole blood folate in LBW newborns than in respective control newborns. 26, 38 In contrast, Relton et al.
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found no association between CBE folate and birth weight in term newborns. Numerous studies have demonstrated associations between maternal folate levels or folate intake during the different stages of pregnancy and birth outcomes. [10] [11] [12] [13] [14] [15] [16] [38] [39] [40] [41] [42] [43] In the first trimester, low maternal plasma folate levels as well as high maternal homocysteine levels were associated with LBW and lower placental weight and increased the risks for SGA, preterm birth and preeclampsia. 10, 13 Maternal erythrocyte folate during early pregnancy was a significant positive predictor of birth weight 11, 40 and the supplemental daily intake of folic acid during early-to-mid gestation was significantly associated with a reduced risk for preterm birth, LBW and SGA. 14 In the third trimester, association between low maternal serum folate and an increased risk for preterm birth and LBW were found. 12 At delivery, high maternal homocysteine, accompanied by low folate concentrations, have been related to preterm birth, preterm birth due to preeclampsia and lower birth weight in preterms. 15 Several studies have found these associations to be true also in late pregnancy and at delivery, 16, 38, 41 whereas in the second or third trimester other studies did not find any association between low maternal plasma folate and GA, birth weight, newborn's length and head circumference. 42, 43 Nevertheless, these findings indicate the importance of an optimal status as early as in the periconceptional period.
Thiamine requirement is related to the energy metabolism and body weight. Thus, term newborns may show reduced thiamine concentrations due to an increased thiamine catabolism. 25 Erythrocyte transketolase activity, a functional measure of thiamine coenzyme activity, in maternal as well as in infant erythrocytes, was negatively correlated with birth weight, newborn's length and head circumference, although these relations were not statistically significant. 44 Low maternal thiamine status was associated with an increased risk of LBW in term newborns, 45 whereas other studies found no difference in maternal or cord-blood thiamine between LBW newborns and controls. 26 In our group of late preterms, TDP in CBEs was lower in multiple births than in singletons. This may be attributed to the fact that energy metabolism is altered in multiple pregnancies. Metabolic demands of women carrying out multiple births are increased by about 10% compared with those carrying out singletons. 46 Hence, increased maternal intake of thiamine could help to satisfy metabolic requirements of the fetuses. Dietary
Reference Intake values regarding micronutrients for women pregnant with multiple births still need to be established. 46 Baker et al. 47 measured maternal micronutrients including thiamine in blood from 563 US women throughout pregnancy and found evident deficiency of thiamine. Thus, thiamine intake during pregnancy may be insufficient even in Western countries, especially in multiple gestations.
In a recent review by van Uitert et al. 17 on the effect of maternal folate status on fetal growth it was concluded that maternal folic acid use as early as in the first trimester may be beneficial for fetal growth parameters. The strongest positive associations were found between birth weight and maternal erythrocyte folate, supplemental folic acid use and dietary folate intake. 17 Our results and those from previous studies support the idea that an optimal folate status in the periconceptional period and during early pregnancy is likely to reduce the risk of preterm birth and SGA offspring. Further studies are required to confirm that a higher thiamine intake of women carrying multiple births may be able to avoid a low thiamine status in multiple births and to show whether multiple births would benefit from these higher intakes. In 2001, the Institute of Medicine set recommended daily allowances for pregnant women for thiamine at 1.4 mg and for folate at 600 mg dietary folate equivalent. 48 These recommended daily allowances were defined only with regard to maintain normal physiological erythrocyte folate and transketolase activity and not concerning the improvement of birth outcomes. To compensate for the higher demands, the status, reflected by blood concentrations, can be easily modified by nutrition and dietary micronutrient supplements. This should ideally occur before conception or at an early time in pregnancy to guarantee the supply throughout entire pregnancy. This would improve both maternal and newborn's micronutrient status and may further improve birth outcomes and reduce the risk for preterm delivery. A study in Greece showed that women who reported supplemental folic acid use in early-to-mid pregnancy [14] [15] [16] [17] [18] weeks gave birth to neonates with significantly higher CBE folate concentrations, compared with newborns from women who did not use folic acid supplements (P ¼ 0.05).
14 A regular and consequent supplemental folic acid use before conception could therefore effectively support the supplementation during 
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: n ¼ 29/117 (25%).
Folate and thiamine status in preterms and terms D Weber et al pregnancy and may, in fact, result in a higher erythrocyte folate status of the newborn at delivery. Furthermore, maternal erythrocyte folate measured in early gestation correlated highly significantly with CBE folate at birth. 11 The present study had certain limitations, which deserve acknowledgement. There was no sufficient documentation of maternal smoking status, nutrition (including the use of micronutrient supplements) and oral glucose tolerance tests. Smoking status is a known risk factor for SGA. 49 However, the inclusion of smoking as a cofactor did not change our main results of the models regarding determinants for cord-blood vitamins and birth outcomes. 5MTHF was still positively associated with GA, birth weight and newborn's length, whereas TDP was still inversely associated with GA. Still, the true effect of smoking as a confounder in our study cannot be assessed. Future studies should include the assessment of smoking prevalence of all the participating women and ideally carry out cotinine measurement as a gold standard, as studies have shown that smoking is significantly underestimated by 25% in pregnant women who smoke but do not report it. 50 We regard our study as a hypothesis-generating study providing fruitful ground for further research. Our results can be used to design future studies that can confirm the positive impact of sufficient periconceptional folate and thiamine status on birth outcomes. A larger confirmatory study should ideally also focus on maternal dietary intake and micronutrient status during an early stage of pregnancy, with a follow-up until delivery, together with cord-blood measurement and maternal background data known to significantly affect birth outcomes. These background data will be helpful to verify the associations found in our study.
